You are currently viewing a new version of our website. To view the old version click .
Pharmaceuticals
  • Correction
  • Open Access

19 August 2025

Correction: Wang et al. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000

,
,
,
,
,
,
,
,
and
1
School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, D02 R590 Dublin, Ireland
2
Department of Pharmaceutical Chemistry, College of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Molecular Design Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, D02 R590 Dublin, Ireland
4
School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, D02 R590 Dublin, Ireland
This article belongs to the Section Medicinal Chemistry

Error in Figure

In the original publication [1], there was a mistake in Figure 9 as published. In Figure 9, CA-4 (0.05 μM) should be corrected to CA-4 (0.01 μM). Corrected Figure 9 appears below.
Figure 9. β-lactam compound 9q induces depolymerization of the microtubule network in MCF-7 breast cancer cells.

Text Correction

A correction has been made to the last paragraph of Section 2.4.4. Tubulin Polymerisation Effects of 3-(Prop-1-en-2-yl)azetidinones, 3-Allylazetidinones and 3-butadienylazetidinones: “CA-4 (50 nM)” should be “CA-4 (10 nM)”.
A correction has been made to Section 3.17.8. Immunofluorescence Microscopy: “9q (50 nM, 100 nM and 500 nM)” should be “9q (10 nM, 100 nM and 500 nM)”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Wang, S.; Malebari, A.M.; Greene, T.F.; Kandwal, S.; Fayne, D.; Nathwani, S.M.; Zisterer, D.M.; Twamley, B.; O’Boyle, N.M.; Meegan, M.J. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells. Pharmaceuticals 2023, 16, 1000. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.